Ikekawa A, Ikekawa S
Yakugaku Zasshi. 2001 Dec;121(12):845-73. doi: 10.1248/yakushi.121.845.
A small knowledge base was created by organizing the Human Genome Project (HGP) and its related issues in "Science" magazines between 1996 and 2000. This base revealed the stunning achievement of HGP and a private venture and its impact on today's biology and life science. In the mid-1990, they encouraged the development of advanced high throughput automated DNA sequencers and the technologies that can analyse all genes at once in a systematic fashion. Using these technologies, they completed the genome sequence of human and various other organisms. These fruits opened the door to comparative genomics, functional genomics, the interdisprinary field between computer and biology, and proteomics. They have caused a shift in biological investigation from studying single genes or proteins to studying all genes or proteins at once, and causing revolutional changes in traditional biology, drug discovery and therapy. They have expanded the range of potential drug targets and have facilitated a shift in drug discovery programs toward rational target-based strategies. They have spawned pharmacogenomics that could give rise to a new generation of highly effective drugs that treat causes, not just symptoms. They should also cause a migration from the traditional medications that are safe and effective for every members of the population to personalized medicine and personalized therapy.
通过整理1996年至2000年间《科学》杂志上关于人类基因组计划(HGP)及其相关问题的内容,创建了一个小型知识库。这个知识库展示了人类基因组计划和一家私人企业的惊人成就及其对当今生物学和生命科学的影响。在20世纪90年代中期,他们推动了先进的高通量自动化DNA测序仪以及能够系统地一次性分析所有基因的技术的发展。利用这些技术,他们完成了人类和各种其他生物体的基因组序列测定。这些成果为比较基因组学、功能基因组学、计算机与生物学的交叉领域以及蛋白质组学打开了大门。它们导致了生物学研究从研究单个基因或蛋白质转向一次性研究所有基因或蛋白质,并在传统生物学、药物发现和治疗方面引发了革命性变化。它们扩大了潜在药物靶点的范围,并推动了药物发现计划向基于合理靶点的策略转变。它们催生了药物基因组学,这可能会产生新一代不仅治疗症状,还治疗病因的高效药物。它们还应该促使从对人群中每个成员都安全有效的传统药物向个性化医学和个性化治疗转变。